Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci


Play all audios:


ABSTRACT Ankylosing spondylitis is a common, highly heritable inflammatory arthritis affecting primarily the spine and pelvis. In addition to _HLA-B*27_ alleles, 12 loci have previously been


identified that are associated with ankylosing spondylitis in populations of European ancestry, and 2 associated loci have been identified in Asians. In this study, we used the Illumina


Immunochip microarray to perform a case-control association study involving 10,619 individuals with ankylosing spondylitis (cases) and 15,145 controls. We identified 13 new risk loci and 12


additional ankylosing spondylitis–associated haplotypes at 11 loci. Two ankylosing spondylitis–associated regions have now been identified encoding four aminopeptidases that are involved in


peptide processing before major histocompatibility complex (MHC) class I presentation. Protective variants at two of these loci are associated both with reduced aminopeptidase function and


with MHC class I cell surface expression. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access


through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink *


Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional


subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS HLA ALLELE-CALLING USING MULTI-ANCESTRY WHOLE-EXOME SEQUENCING FROM THE UK BIOBANK IDENTIFIES


129 NOVEL ASSOCIATIONS IN 11 AUTOIMMUNE DISEASES Article Open access 03 November 2023 TUTORIAL: A STATISTICAL GENETICS GUIDE TO IDENTIFYING HLA ALLELES DRIVING COMPLEX DISEASE Article 26


July 2023 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES SJÖGREN’S RISK LOCI WITH FUNCTIONAL IMPLICATIONS IN IMMUNE AND GLANDULAR CELLS Article Open access 27 July 2022 REFERENCES * Braun, J.,


Listing, J. & Sieper, J. Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al—Reply. _Arthritis Rheum._ 52, 4049–4050


(2005). Article  Google Scholar  * Ng, S.C. et al. Epidemiology of spondyloarthritis in the People's Republic of China: review of the literature and commentary. _Semin. Arthritis


Rheum._ 37, 39–47 (2007). Article  PubMed  Google Scholar  * Brown, M.A., Laval, S.H., Brophy, S. & Calin, A. Recurrence risk modelling of the genetic susceptibility to ankylosing


spondylitis. _Ann. Rheum. Dis._ 59, 883–886 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Brown, M.A. et al. Susceptibility to ankylosing spondylitis in twins: the role of


genes, HLA, and the environment. _Arthritis Rheum._ 40, 1823–1828 (1997). Article  CAS  PubMed  Google Scholar  * Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four


diseases identifies autoimmunity variants. _Nat. Genet._ 39, 1329–1337 (2007). Article  CAS  PubMed  Google Scholar  * Evans, D.M. et al. Interaction between _ERAP1_ and HLA-B27 in


ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. _Nat. Genet._ 43, 761–767 (2011). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Reveille, J.D. et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. _Nat. Genet._ 42, 123–127 (2010). Article  CAS  PubMed 


PubMed Central  Google Scholar  * Lin, Z. et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. _Nat. Genet._ 44, 73–77 (2012).


Article  CAS  Google Scholar  * Cortes, A. & Brown, M.A. Promise and pitfalls of the Immunochip. _Arthritis Res. Ther._ 13, 101 (2011). Article  PubMed  PubMed Central  Google Scholar 


* Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. _Nat. Genet._ 43, 1193–1201 (2011). Article  CAS  PubMed


  PubMed Central  Google Scholar  * Ferreira, M.A. et al. Identification of _IL6R_ and chromosome 11q13.5 as risk loci for asthma. _Lancet_ 378, 1006–1014 (2011). Article  CAS  PubMed 


PubMed Central  Google Scholar  * Melzer, D. et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). _PLoS Genet._ 4, e1000072 (2008). Article  CAS  PubMed


  PubMed Central  Google Scholar  * Mizuki, N. et al. Genome-wide association studies identify _IL23R–IL12RB2_ and _IL10_ as Behcet′s disease susceptibility loci. _Nat. Genet._ 42, 703–706


(2010). Article  CAS  PubMed  Google Scholar  * Remmers, E.F. et al. Genome-wide association study identifies variants in the MHC class I, _IL10_, and _IL23R-IL12RB2_ regions associated with


Behcet's disease. _Nat. Genet._ 42, 698–702 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ait Badi, M.A. et al. Skeletal manifestations in Behcet's disease. A


report of 79 cases. _Rev. Med. Interne_ 29, 277–282 (2008). Article  CAS  PubMed  Google Scholar  * Harvey, D. et al. A common functional variant of endoplasmic reticulum aminopeptidase 2


(_ERAP2_) that reduces major histocompatibility complex class I expression is not associated with ankylosing spondylitis. _Rheumatology_ 50, 1720–1721 (2011). Article  CAS  PubMed  PubMed


Central  Google Scholar  * Tsui, F.W. et al. Association of an _ERAP1-ERAP2_ haplotype with familial ankylosing spondylitis. _Ann. Rheum. Dis._ 69, 733–736 (2010). Article  CAS  PubMed 


Google Scholar  * Evnouchidou, I. et al. A common single nucleotide polymorphism in Endoplasmic Reticulum Aminopeptidase 2 induces a specificity switch that leads to altered antigen


processing. _J. Immunol._ 189, 2383–2392 (2012). Article  CAS  PubMed  Google Scholar  * Andrés, A.M. et al. Balancing selection maintains a form of _ERAP2_ that undergoes nonsense-mediated


decay and affects antigen presentation. _PLoS Genet._ 6, e1001157 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Lévy, F. et al. The final N-terminal trimming of a


subaminoterminal proline-containing HLA class I–restricted antigenic peptide in the cytosol is mediated by two peptidases. _J. Immunol._ 169, 4161–4171 (2002). Article  PubMed  Google


Scholar  * Xia, Z. et al. A 17q12 allele is associated with altered NK cell subsets and function. _J. Immunol._ 188, 3315–3322 (2012). Article  CAS  PubMed  Google Scholar  * Trynka, G. et


al. Chromatin marks identify critical cell types for fine mapping complex trait variants. _Nat. Genet._ 45, 124–130 (2013). Article  CAS  PubMed  Google Scholar  * ENCODE Project Consortium.


An integrated encyclopedia of DNA elements in the human genome. _Nature_ 489, 57–74 (2012). * Ferreira, M.A. et al. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with


risk of type 1 diabetes and HIV-1 immune control. _Am. J. Hum. Genet._ 86, 88–92 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Davidson, S.I. et al. Association of _ERAP1_,


but not _IL23R_, with ankylosing spondylitis in a Han Chinese population. _Arthritis Rheum._ 60, 3263–3268 (2009). Article  CAS  PubMed  Google Scholar  * Kumar, P., Henikoff, S. & Ng,


P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. _Nat. Protoc._ 4, 1073–1081 (2009). Article  CAS  PubMed  Google Scholar  *


Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. _Nat. Methods_ 7, 248–249 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Sato, K. et


al. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to


Crohn's disease in the Japanese population. _J. Clin. Immunol._ 29, 815–825 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  * Strange, A. et al. A genome-wide association


study identifies new psoriasis susceptibility loci and an interaction between _HLA-C_ and _ERAP1_. _Nat. Genet._ 42, 985–990 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  *


Ban, M. et al. Replication analysis identifies _TYK2_ as a multiple sclerosis susceptibility factor. _Eur. J. Hum. Genet._ 17, 1309–1313 (2009). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. _Nature_ 441, 235–238 (2006). Article  CAS  PubMed 


Google Scholar  * Kenna, T.J. et al. Enrichment of circulating interleukin-17–secreting interleukin-23 receptor–positive γ/δ T cells in patients with active ankylosing spondylitis.


_Arthritis Rheum._ 64, 1420–1429 (2012). Article  CAS  PubMed  Google Scholar  * Appel, H. et al. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that


the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. _Arthritis Res. Ther._ 13, R95 (2011). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Pearce, E.L. et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. _Science_ 302, 1041–1043 (2003). Article  CAS  PubMed  Google Scholar  *


Yagi, R. et al. The transcription factor GATA3 actively represses RUNX3 protein–regulated production of interferon-γ. _Immunity_ 32, 507–517 (2010). Article  CAS  PubMed  PubMed Central 


Google Scholar  * Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. _J. Exp. Med._ 206, 51–59 (2009). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Intlekofer, A.M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. _Science_ 321, 408–411 (2008).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Park, J.H. et al. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the


differentiation of cytotoxic-lineage T cells. _Nat. Immunol._ 11, 257–264 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Rakowski, L.A. et al. Convergence of the ZMIZ1 and


NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. _Cancer Res._ 73, 930–941 (2013). Article  CAS  PubMed  Google Scholar  * Hartgring, S.A., Willis, C.R., Bijlsma, J.W., Lafeber,


F.P. & van Roon, J.A. Interleukin-7 aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. _Arthritis Res.


Ther._ 14, R137 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Muto, A. et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class


switch. _EMBO J._ 29, 4048–4061 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Song, I.H. et al. Different response to rituximab in tumor necrosis factor blocker–naive


patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. _Arthritis Rheum._ 62, 1290–1297 (2010).


Article  CAS  PubMed  Google Scholar  * Huang, X., Li, Y., Tanaka, K., Moore, K.G. & Hayashi, J.I. Cloning and characterization of Lnk, a signal transduction protein that links T-cell


receptor activation signal to phospholipase Cγ1, Grb2, and phosphatidylinositol 3-kinase. _Proc. Natl. Acad. Sci. USA_ 92, 11618–11622 (1995). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Evnouchidou, I. et al. Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation _in vitro_ by


influencing basic enzymatic properties of the enzyme. _J. Immunol._ 186, 1909–1913 (2011). Article  CAS  PubMed  Google Scholar  * Saveanu, L. et al. Concerted peptide trimming by human


ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. _Nat. Immunol._ 6, 689–697 (2005). Article  CAS  PubMed  Google Scholar  * Colbert, R.A. et al. HLA-B27 misfolding


activates the IL-23/IL-17 axis via the unfolded protein response in transgenic rats: evidence for a novel mechanism of inflammation. _Arthritis Rheum._ 1283, S515 (2007). Google Scholar  *


Karaderi, T. et al. Evidence of genetic association between _TNFRSF1A_ encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK Caucasians. _Clin. Exp. Rheumatol._


30, 110–113 (2012). CAS  PubMed  Google Scholar  * Gregory, A.P. et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. _Nature_ 488, 508–511 (2012).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Hemminki, K., Li, X., Sundquist, K. & Sundquist, J. Familial association of inflammatory bowel diseases with other autoimmune and


related diseases. _Am. J. Gastroenterol._ 105, 139–147 (2010). Article  PubMed  Google Scholar  * Thjodleifsson, B., Geirsson, A.J., Bjornsson, S. & Bjarnason, I. A common genetic


background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. _Arthritis Rheum._ 56, 2633–2639 (2007). Article  PubMed  Google Scholar  * Danoy, P. et


al. Association of variants at 1q32 and _STAT3_ with ankylosing spondylitis suggests genetic overlap with Crohn's disease. _PLoS Genet._ 6, e1001195 (2010). Article  CAS  PubMed  PubMed


Central  Google Scholar  * Laukens, D. et al. Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis. _PLoS ONE_ 5, e13795 (2010).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. _Nat.


Genet._ 42, 1118–1125 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple


sclerosis. _Nature_ 476, 214–219 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Onozawa, Y. et al. Activation of T cell death–associated gene 8 regulates the cytokine


production of T cells and macrophages _in vitro_. _Eur. J. Pharmacol._ 683, 325–331 (2012). Article  CAS  PubMed  Google Scholar  * Ryder, C., McColl, K., Zhong, F. & Distelhorst, C.W.


Acidosis promotes Bcl-2 family mediated evasion of apoptosis: involvement of acid-sensing G protein–coupled receptor GPR65 signaling to MEK/ERK. _J. Biol. Chem._ 287, 27863–27875 (2012).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Khan, M.A., Kushner, I. & Braun, W.E. Association of HLA-A2 with uveitis in HLA-B27 positive patients with ankylosing spondylitis.


_J. Rheumatol._ 8, 295–298 (1981). CAS  PubMed  Google Scholar  * Liu, J.B. et al. Association of vitiligo with HLA-A2: a meta-analysis. _J. Eur. Acad. Dermatol. Venereol._ 21, 205–213


(2007). Article  PubMed  Google Scholar  * Noble, J.A. et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. _Diabetes_ 59,


2972–2979 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * van der Linden, S., Valkenburg, H.A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A


proposal for modification of the New York criteria. _Arthritis Rheum._ 27, 361–368 (1984). Article  CAS  PubMed  Google Scholar  * Shah, T.S. et al. optiCall: a robust genotype-calling


algorithm for rare, low-frequency and common variants. _Bioinformatics_ 28, 1598–1603 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Fraley, C. & Raftery, A.E.


Model-based clustering, discriminant analysis, and density estimation. _J. Am. Stat. Assoc._ 97, 611–631 (2002). Article  Google Scholar  * Purcell, S. et al. PLINK: a tool set for


whole-genome association and population-based linkage analyses. _Am. J. Hum. Genet._ 81, 559–575 (2007). CAS  PubMed  PubMed Central  Google Scholar  * Lippert, C. et al. FaST linear mixed


models for genome-wide association studies. _Nat. Methods_ 8, 833–835 (2011). Article  CAS  PubMed  Google Scholar  * Pruim, R.J. et al. LocusZoom: regional visualization of genome-wide


association scan results. _Bioinformatics_ 26, 2336–2337 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * 1000 Genomes Project Consortium.. A map of human genome variation


from population-scale sequencing. _Nature_ 467, 1061–1073 (2010). * Li, Y., Willer, C.J., Ding, J., Scheet, P. & Abecasis, G.R. MaCH: using sequence and genotype data to estimate


haplotypes and unobserved genotypes. _Genet. Epidemiol._ 34, 816–834 (2010). Article  PubMed  PubMed Central  Google Scholar  * Wellcome Trust Case Control Consortium. Genomewide association


study of 14,000 cases of seven common diseases and 3000 controls. _Nature_ 447, 661–678 (2007). Download references ACKNOWLEDGEMENTS We thank all participating subjects with ankylosing


spondylitis and healthy individuals who provided the DNA and clinical information necessary for this study. The Wellcome Trust Case Control Consortium 2 project is funded by the Wellcome


Trust (083948/Z/07/Z). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02), and of the


UK National Blood Service controls, funded by the Wellcome Trust. We thank J.C. Barrett for contributing the design of the Immunochip and for helpful analytical discussion, as well as E.


Gray, S. Bumpstead, D. Simpkin and the staff of the Wellcome Trust Sanger Institute Sample Management and Genotyping teams for their genotyping and analytical contributions. The


Australo-Anglo-American Spondyloarthritis Consortium (TASC) study was funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants P01-052915 and


R01-AR046208. Funding was also received from University of Texas at Houston Clinical and Translational Science Award (CTSA) UL1RR024188, Cedars-Sinai General Clinical Research Center (GCRC)


grant MO1-RR00425, the Intramural Research Program, NIAMS, US National Institutes of Health and the Rebecca Cooper Foundation (Australia). This study was funded, in part, by Arthritis


Research UK (grants 19536 and 18797), by the Wellcome Trust (grant 076113) and by the Oxford Comprehensive Biomedical Research Centre ankylosing spondylitis chronic disease cohort (theme


A91202). We thank A. Harrison (University of Otago) for his contribution to the New Zealand ankylosing spondylitis cohort. H.X. was funded by National Natural Science Foundation of China


grants 81020108029 and 30872339. Portuguese sample collection was performed by COnhecer a Realidade PORtuguesa sobre a Espondilite Anquilosante (CORPOREA Study Group), coordinated by


F.M.P.-S. and supported by Bolsa Investigação da Sociedade Portuguesa de Reumatologia/Schering-Plough 2007. The Spanish ankylosing spondylitis case collection was supported by Spanish grant


FICYT PC-10-70-Fondos FEDER European Union. The Spondyloarthritis Research Consortium of Canada (SPARCC) was funded by a National Research Initiative Award from the Arthritis Society


(Canada). French sample collection was performed by the Groupe Française d'Etude Génétique des Spondylarthrites, coordinated by R. Said-Nahal and funded by Agence Nationale de Recherche


GEnetics, Microbiota, Inflammation and Spondyloarthritis (GEMISA) grant ANR-10-MIDI-0002. We thank the Norwegian Bone Marrow Donor registry for providing data from healthy Norwegian


controls. W.P.M. is a Medical Scientist of Alberta Innovates–Health Solutions. The Psoriatic Arthritis Program is supported by the Krembil Foundation and the Arthritis Society. P.C.R. is


funded by the National Health and Medical Research Council (Australia) (NHMRC) and Arthritis Australia. J.Y. is supported by NHMRC grants 613672 and 1011506. M. Ward is supported by the


Intramural Research Program, NIAMS, US National Institutes of Health. D.E. is supported by the research council of Ghent University and by the Fund for Scientific Research Flanders. M.A.B.


is funded by a National Health and Medical Research Council (Australia) Senior Principal Research Fellowship, and support for this study was received from a National Health and Medical


Research Council (Australia) program grant (566938) and project grant (569829) and from the Australian Cancer Research Foundation and the Rebecca Cooper Medical Research Foundation. We thank


A. Gardiner and the Brisbane Convention and Exhibition Centre for their assistance in preparing the manuscript. We are also very grateful for the invaluable support received from the


National Ankylosing Spondylitis Society (UK) and the Spondyloarthritis Association of America in case recruitment. Additional financial and technical support for subject recruitment was


provided by the NIHR Oxford Musculoskeletal Biomedical Research Unit and NIHR Thames Valley Comprehensive Local Research and by an unrestricted educational grant from Abbott Laboratories.


AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia Adrian Cortes, Johanna Hadler, 


Philip C Robinson, Paul Leo, Katie Cremin, Karena Pryce, Jessica Harris, Linda A Bradbury, Tony J Kenna, Jian Yang & Matthew A Brown * National Institute for Health Research (NIHR)


Oxford Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, Headington, Oxford, UK Jenny P Pointon, Tugce Karaderi, Louise Appleton, Claire Farrah, Jonathan Lau, Paul


Bowness & Bryan Paul Wordsworth * Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea Seunghun Lee, Kyung Bin Joo & Tae-Hwan Kim


* Department of Medicine, Division of Rheumatology, Eulji University Hospital, Daejeon, Republic of Korea Seung-Cheol Shim * Department of Medicine/Rheumatology, Cedars-Sinai Medical Center,


Los Angeles, California, USA Michael Weisman * National Institute of Arthritis and Musculoskeletal and Skin Diseases, US National Institutes of Health, Bethesda, Maryland, USA Michael Ward


* Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center at Houston, Houston, Texas, USA Xiaodong Zhou & John D Reveille * Institut Cochin, Université


Paris–Descartes, Centre National de Recherche Scientifique (CNRS) Unité Mixte de Recherhce (UMR) 8104, Institut National de la Santé et de la Recherche Médicale (INSERM) U1016, Paris, France


Henri-Jean Garchon, Gilles Chiocchia & Maxime Breban * Division of Rheumatology, Ambroise Paré Hospital, Assistance Publique–Hôpitaux de Paris, Versailles-Saint-Quentin en Yvelines


University, Boulogne-Billancourt, France Henri-Jean Garchon & Maxime Breban * University Hospital North Norway, Tromso, Norway Johannes Nossent * Division of Medicine, Royal Darwin


Hospital, Darwin, Northern Territory, Australia Johannes Nossent * Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway Benedicte A Lie * Department


of Immunology, Oslo University Hospital, Oslo, Norway Benedicte A Lie * Department of Rheumatology, University Hospital Oslo, Oslo, Norway Øystein Førre * Centre for Vascular Prevention,


Danube-University Krems, Krems, Austria Jaakko Tuomilehto * Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland Jaakko Tuomilehto * King Abdulaziz


University, Jeddah, Saudi Arabia Jaakko Tuomilehto * Paijat-Hame Central Hospital, Lahti, Finland Kari Laiho * Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second


Military Medical University, Shanghai, China Lei Jiang, Yu Liu, Xin Wu & Huji Xu * Department of Rheumatology, Ghent University Hospital, Ghent, Belgium Dirk Elewaut * Department of


Rheumatology, Hospital General de México, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, México Ruben Burgos-Vargas * Department of Medicine, Dunedin School of


Medicine, University of Otago, Dunedin, New Zealand Simon Stebbings * Division of Rheumatology, Toronto Western Hospital, Toronto, Ontario, Canada Nigil Haroon & Robert D Inman *


Queensland Institute of Medical Research, Royal Brisbane Hospital, Herston, Queensland, Australia Manuel A Ferreira * Rheumatology Department, Hospital Puerta de Hierro, Madrid, Spain Juan


Mulero * Rheumatology Department, Complejo Hospitalario La Coruña, Instituto de Investigación Biomédica A Coruña (INIBIC), La Coruña, Spain Jose Luis Fernandez-Sueiro * Rheumatology


Department, Hospital Marqués de Valcecilla, Instituto de Formación e Investigación Marqués de Valcecillas (IFIMAV), Santander, Spain Miguel A Gonzalez-Gay * Department of Immunology,


Asturias Central University Hospital, Oviedo, Spain Carlos Lopez-Larrea * Fundación Renal Iñigo Alvarez de Toledo, Madrid, Spain Carlos Lopez-Larrea * Wellcome Trust Sanger Institute,


Cambridge, UK Panos Deloukas * Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK Peter Donnelly * Department of Rheumatology, Norfolk and Norwich University


Hospital, Norwich, UK Karl Gafney * Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK Hill Gaston * Division of Rheumatology, University of Toronto,


Toronto, Ontario, Canada Dafna D Gladman * Toronto Western Research Institute, Toronto, Ontario, Canada Dafna D Gladman * Psoriatic Arthritis Program, University Health Network, Toronto,


Ontario, Canada Dafna D Gladman * Memorial University of Newfoundland, St. John's, Newfoundland, Canada Proton Rahman * Department of Medicine, University of Alberta, Edmonton, Alberta,


Canada Walter P Maksymowych * Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands J Bart A


Crusius * Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands Irene E van der Horst-Bruinsma * Department of Medicine, Division of Allergy, Immunology,


Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan Chung-Tei Chou * School of Medicine, National Yang-Ming University, Taipei, Taiwan Chung-Tei Chou * Division of Rheumatology,


Spondyloarthropathy Group, Hospital Militar Central, Universidad de La Sabana, Bogotá, Colombia., Raphael Valle-Oñate & Consuelo Romero-Sánchez * Helgelandssykehuset, Mo i Rana, Norway


Inger Myrnes Hansen * Chronic Diseases Research Centre (CEDOC), Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal Fernando M Pimentel-Santos * Department of


Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway Vibeke Videm * Department of Immunology and Transfusion


Medicine, Trondheim University Hospital, Trondheim, Norway Vibeke Videm * Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada,


Spain Javier Martin * Medical Research Council (MRC) Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, Bristol, UK David M Evans CONSORTIA


INTERNATIONAL GENETICS OF ANKYLOSING SPONDYLITIS CONSORTIUM (IGAS) * Adrian Cortes * , Johanna Hadler * , Jenny P Pointon * , Philip C Robinson * , Tugce Karaderi * , Paul Leo * , Katie


Cremin * , Karena Pryce * , Jessica Harris * , Seunghun Lee * , Kyung Bin Joo * , Seung-Cheol Shim * , Michael Weisman * , Michael Ward * , Xiaodong Zhou * , Henri-Jean Garchon * , Gilles


Chiocchia * , Johannes Nossent * , Benedicte A Lie * , Øystein Førre * , Jaakko Tuomilehto * , Kari Laiho * , Lei Jiang * , Yu Liu * , Xin Wu * , Linda A Bradbury * , Dirk Elewaut * , Ruben


Burgos-Vargas * , Simon Stebbings * , Louise Appleton * , Claire Farrah * , Jonathan Lau * , Tony J Kenna * , Nigil Haroon * , Manuel A Ferreira * , Jian Yang * , Juan Mulero * , Jose Luis


Fernandez-Sueiro * , Miguel A Gonzalez-Gay * , Carlos Lopez-Larrea * , Panos Deloukas * , Peter Donnelly * , Australo-Anglo-American Spondyloarthritis Consortium (TASC) * , Groupe Française


d'Etude Génétique des Spondylarthrites (GFEGS) * , Nord-Trøndelag Health Study (HUNT) * , Spondyloarthritis Research Consortium of Canada (SPARCC) * , Wellcome Trust Case Control


Consortium 2 (WTCCC2) * , Paul Bowness * , Karl Gafney * , Hill Gaston * , Dafna D Gladman * , Proton Rahman * , Walter P Maksymowych * , Huji Xu * , J Bart A Crusius * , Irene E van der


Horst-Bruinsma * , Chung-Tei Chou * , Raphael Valle-Oñate * , Consuelo Romero-Sánchez * , Inger Myrnes Hansen * , Fernando M Pimentel-Santos * , Robert D Inman * , Vibeke Videm * , Javier


Martin * , Maxime Breban * , John D Reveille * , David M Evans * , Tae-Hwan Kim * , Bryan Paul Wordsworth *  & Matthew A Brown CONTRIBUTIONS J. Hadler, K.C., K.P. and J. Harris performed


genotyping. A.C., P.C.R., T.K., P.L., J.Y., M.A.B. and D.M.E. performed statistical analyses. J.P.P., S.L., K.B.J., S.-C.S., M. Weisman, M. Ward, X.Z., H.-J.G., G.C., J.N., B.A.L., Ø.F.,


J.T., K.L., L.J., Y.L., X.W., L.A.B., D.E., R.B.-V., S.S., L.A., C.F., J.L., N.H., J. Mulero, J.L.F.-S., M.A.G.-G., C.L.-L., P. Deloukas, P. Donnelly, P.B., K.G., H.G., D.D.G., P.R., W.P.M.,


H.X., J.B.A.C., I.E.v.d.H.-B., C.-T.C., R.V.-O., C.R.-S., I.M.H., F.M.P.-S., R.D.I., V.V., J. Martin, M.B., J.D.R. and T.-H.K. all contributed to subject recruitment and study design. A.C.,


M.A.B., D.M.E. and B.P.W. wrote the manuscript, and all authors contributed to manuscript drafting and reviewed the final manuscript. T.J.K. performed cell count and IL-6R studies in


ankylosing spondylitis cases and controls. M.A.F. performed GWAS of cell counts in controls. CORRESPONDING AUTHOR Correspondence to Matthew A Brown. ETHICS DECLARATIONS COMPETING INTERESTS


The author declare no competing financial interests. ADDITIONAL INFORMATION Details appear in the Supplementary Note. Details appear in the Supplementary Note. Details appear in the


Supplementary Note. Details appear in the Supplementary Note. Details appear in the Supplementary Note. SUPPLEMENTARY INFORMATION SUPPLEMENTARY TEXT AND FIGURES Supplementary Tables 1–11,


Supplementary Figures 1–12, Supplementary Note (PDF 13979 kb) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE International Genetics of Ankylosing


Spondylitis Consortium (IGAS). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. _Nat Genet_ 45, 730–738 (2013).


https://doi.org/10.1038/ng.2667 Download citation * Received: 10 October 2012 * Accepted: 15 May 2013 * Published: 09 June 2013 * Issue Date: July 2013 * DOI: https://doi.org/10.1038/ng.2667


SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy


to clipboard Provided by the Springer Nature SharedIt content-sharing initiative